Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.80
$0.00 (0.00%)
After-hours:
Nov 2, 2026, 4:34 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 83K | 298K | 231K | 468K | 177K | 401K |
Cost of Revenue | 80.59K | 48.7K | 1.67M | 3.25M | 2.19M | 2.25M | 2.25M | 2.7M | 2.41M | 2.64M | 2.01M |
Gross Profit | -80.59K | -48.7K | -1.67M | -3.25M | -2.19M | -2.17M | -1.95M | -2.47M | -1.95M | -2.47M | -1.61M |
Operating Income | -4.75M | -4.72M | -4.02M | -4.98M | -4.22M | -3.77M | -4.24M | -3.79M | -3.78M | -3.76M | -3.23M |
Interest Income | 92.83K | 53.67K | n/a | n/a | 88K | 40K | 2K | 6K | 18K | 22K | 22K |
Pretax Income | -1.83M | -2.5M | -3.97M | -2.55M | -3.43M | -3.63M | -3.86M | -5.09M | -3.4M | -2.72M | -3.39M |
Net Income | -1.88M | -2.56M | -3.81M | -2.42M | -3.31M | -3.51M | -3.57M | -4.6M | -3.06M | -2.31M | -3.15M |
Selling & General & Admin | 1.69M | 2.46M | 2.38M | 1.76M | 2.03M | 741K | 2.29M | 1.33M | 1.85M | 1.29M | 1.66M |
Research & Development | 2.97M | 2.28M | 1.67M | 3.25M | 2.19M | 1.82M | 2.25M | 2.7M | 2.41M | 2.64M | 2.01M |
Other Expenses | n/a | -63.85K | -1.69M | -3.28M | -2.19M | -955K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.67M | 4.68M | 2.35M | 1.73M | 2.03M | 1.6M | 1.9M | 2.62M | 1.44M | 227K | 1.76M |
Interest Expense | 5.1K | 20.87K | 100K | 37K | 49K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.75M | 4.72M | 4.02M | 4.98M | 4.22M | 3.85M | 4.16M | 5.31M | 3.85M | 2.87M | 3.77M |
Income Tax Expense | 44.89K | 59.63K | 165K | -125K | -125K | -118K | -288K | -495K | -337K | -410K | -236K |
Shares Outstanding (Basic) | 18.66M | 112.91M | 12.63M | 3.34M | 1.64M | 594.79K | 49.6K | 2.48K | 2.46K | 2.46K | 1.58K |
Shares Outstanding (Diluted) | 18.66M | 112.91M | 12.63M | 3.34M | 1.64M | 594.79K | 49.6K | 2.48K | 2.46K | 2.46K | 1.58K |
EPS (Basic) | n/a | -0.04 | -0.39 | -0.93 | -2.55 | -7.39 | -88.71 | -2.18K | -1.61K | -1.28K | -2.77K |
EPS (Diluted) | n/a | -0.04 | -0.39 | -0.93 | -2.55 | -7.39 | -88.71 | -2.18K | -1.61K | -1.28K | -2.77K |
EBITDA | -4.67M | -4.68M | -3.88M | -4.86M | -3.25M | -2.22M | -4.1M | -3.62M | -3.6M | -3.54M | -3.05M |
EBIT | -4.75M | -4.72M | -4.02M | -4.98M | -3.38M | -2.36M | -4.24M | -3.79M | -3.78M | -3.76M | -3.23M |
Depreciation & Amortization | 80.59K | 48.7K | 140.61K | 116.21K | 136K | 144.22K | 142.63K | 170.93K | 179.75K | 225.92K | 179.87K |
Add to Watchlist
Select watchlists to add or remove BDRX